◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
State Street SPDR S&P Biotech ETF (XBI) ETF Overview
Price history, fund statistics and profile — an exchange-traded fund.
Exchange-Traded Funds · Health · DATA UPDATED 2026-08-16
State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund managed by State Street Investment Management in the "Health" category. It manages roughly $10 billion in assets.
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
Interactive chart & fund stats →
XBI Fund Statistics
| Expense ratio | 0.35% |
| Trailing yield | 0.39% |
| Assets under management | $10 billion |
| Fund category | Health |
| Fund family | State Street Investment Management |
| Inception | 2006-01-31 |
The live price chart, fund profile and news are in the interactive XBI viewer.
Other Companies in Health
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.